| Model Number |
INNOVANCE ANTITHROMBIN |
| Medical Device Problem Code |
Low Test Results (2458)
|
| Health Effect - Clinical Code |
No Clinical Signs, Symptoms or Conditions (4582)
|
| Date of Event |
01/14/2022
|
|
Type of Reportable Event
|
Malfunction
|
|
Additional Manufacturer Narrative
|
|
An outside of the united states (ous) customer contacted a siemens customer care center (ccc).Quality controls (qc) recovered in range at the time of the event.Siemens is investigating the issue.
|
| |
|
Event or Problem Description
|
|
A discordant, falsely low antithrombin (at) result was obtained on a patient sample on a sysmex cs-2500 system using innovance antithrombin reagent.The discordant result was reported to the physician(s) and was questioned.The sample was rerun for at at an alternate laboratory, recovering higher.The higher result was reported, as the correct result, to the physician(s).There are no known reports of patient intervention or adverse health consequences due to the discordant at result.
|
| |
|
Additional Manufacturer Narrative
|
|
Siemens filed the initial mdr 9610806-2022-00007 on 18-feb-2022.Additional information (21-feb-2022): the results were evaluted correctly by the sysmex cs-2500 system software.Quality controls (qc) recovered in range and the issue was limited to one patient sample.Compared to the non-siemens assay used at the alternate laboratory, the innovance antithrombin assay uses an incubation time to facilitate an increased sensitivity to heparin binding site mutations.Sample specific interferences cannot be ruled out as a potential cause of the result discrepancy.The cause of the event is unknown.The reagent is performing according to specifications.No further evaluation of this device is required.
|
| |
|
Search Alerts/Recalls
|